Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T de Witte

Showing results (141-150 of 215) with videos related to

Pageof 22
Sort By:
Bone Marrow Transplantation|March 14, 2012
Prophylaxis and treatment of GVHD after allogeneic haematopoietic SCT: a survey of centre strategies by the European Group for Blood and Marrow TransplantationT Ruutu, A van Biezen, B Hertenstein, et al.
Leukemia|March 16, 2002
Acquired skewing of Lyonization remains stable for a prolonged period in healthy blood donorsJ P van Dijk, L Heuver, E Stevens-Linders, et al.
Bone Marrow Transplantation|August 30, 2008
The harvest and use of autologous back-up grafts for graft failure or severe GVHD after allogeneic hematopoietic stem cell transplantation: a survey of the European Group for Blood and Marrow TransplantationM Stelljes, A van Biezen, S Slavin, et al.
Leukemia|November 21, 2012
Monosomal karyotype predicts poor survival after allogeneic stem cell transplantation in chromosome 7 abnormal myelodysplastic syndrome and secondary acute myeloid leukemiaM van Gelder, L C de Wreede, J Schetelig, et al.
European Journal of Cancer (Oxford, England : 1990)|February 16, 2000
Centre effect on treatment outcome for patients with untreated acute myelogenous leukaemia? An analysis of the AML 8A Study of the Leukemia Cooperative Group of the EORTC and GIMEMA. European Organization for Research and Treatment of Cancer (EORTC) Leukemia Cooperative Group and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA)S Keating, T de Witte, S Suciu, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 20, 2010
[CT colonography as first-line diagnostic procedure in patients with bowel symptoms]Jelle J S Peulen, Marcel T de Witte, Pieter Friederich, et al.
Leukemia|February 20, 1999
Influence of cytotoxicity enhancers in combination with human serum on the activity of CD22-recombinant ricin A against B cell lines, chronic and acute lymphocytic leukemia cellsP J van Horssen, Y V van Oosterhout, S Evers, et al.
Blood|March 1, 1992
Recombinant human granulocyte-macrophage colony-stimulating factor accelerates neutrophil and monocyte recovery after allogeneic T-cell-depleted bone marrow transplantationT De Witte, A Gratwohl, N Van Der Lely, et al.
Annals of Hematology|March 1, 1996
Salvage treatment for primary resistant acute myelogenous leukemia consisting of intermediate-dose cytosine arabinoside and interspaced continuous infusions of idarubicin: a phase-II study (no. 06901) of the EORTC Leukemia Cooperative GroupT De Witte, S Suciu, D Selleslag, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Granulocyte-macrophage colony-stimulating factor associated with induction treatment of acute myelogenous leukemia: a randomized trial by the European Organization for Research and Treatment of Cancer Leukemia Cooperative GroupR Zittoun, S Suciu, F Mandelli, et al.
Pageof 22

Showing results (141-150 of 215) with videos related to

Sort By:
Pageof 22
Bone Marrow Transplantation|March 14, 2012
Prophylaxis and treatment of GVHD after allogeneic haematopoietic SCT: a survey of centre strategies by the European Group for Blood and Marrow TransplantationT Ruutu, A van Biezen, B Hertenstein, et al.
Leukemia|March 16, 2002
Acquired skewing of Lyonization remains stable for a prolonged period in healthy blood donorsJ P van Dijk, L Heuver, E Stevens-Linders, et al.
Bone Marrow Transplantation|August 30, 2008
The harvest and use of autologous back-up grafts for graft failure or severe GVHD after allogeneic hematopoietic stem cell transplantation: a survey of the European Group for Blood and Marrow TransplantationM Stelljes, A van Biezen, S Slavin, et al.
Leukemia|November 21, 2012
Monosomal karyotype predicts poor survival after allogeneic stem cell transplantation in chromosome 7 abnormal myelodysplastic syndrome and secondary acute myeloid leukemiaM van Gelder, L C de Wreede, J Schetelig, et al.
European Journal of Cancer (Oxford, England : 1990)|February 16, 2000
Centre effect on treatment outcome for patients with untreated acute myelogenous leukaemia? An analysis of the AML 8A Study of the Leukemia Cooperative Group of the EORTC and GIMEMA. European Organization for Research and Treatment of Cancer (EORTC) Leukemia Cooperative Group and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA)S Keating, T de Witte, S Suciu, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 20, 2010
[CT colonography as first-line diagnostic procedure in patients with bowel symptoms]Jelle J S Peulen, Marcel T de Witte, Pieter Friederich, et al.
Leukemia|February 20, 1999
Influence of cytotoxicity enhancers in combination with human serum on the activity of CD22-recombinant ricin A against B cell lines, chronic and acute lymphocytic leukemia cellsP J van Horssen, Y V van Oosterhout, S Evers, et al.
Blood|March 1, 1992
Recombinant human granulocyte-macrophage colony-stimulating factor accelerates neutrophil and monocyte recovery after allogeneic T-cell-depleted bone marrow transplantationT De Witte, A Gratwohl, N Van Der Lely, et al.
Annals of Hematology|March 1, 1996
Salvage treatment for primary resistant acute myelogenous leukemia consisting of intermediate-dose cytosine arabinoside and interspaced continuous infusions of idarubicin: a phase-II study (no. 06901) of the EORTC Leukemia Cooperative GroupT De Witte, S Suciu, D Selleslag, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Granulocyte-macrophage colony-stimulating factor associated with induction treatment of acute myelogenous leukemia: a randomized trial by the European Organization for Research and Treatment of Cancer Leukemia Cooperative GroupR Zittoun, S Suciu, F Mandelli, et al.
Pageof 22